|
Market Cap (5-Jun) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUD released this announcement to the ASX on 7 September 2021, 8:54. The announcement is marked as price sensitive, and is 29 page(s) in length and 2.1MB in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Investor Presentation | 7 September 2021, 8:54 |
| Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB | 3 September 2021, 9:04 |
| Preliminary Final Report | 31 August 2021, 10:46 |
| Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB | 26 August 2021, 9:38 |
You must be logged in to post a reply.
